NEW YORK, April 01, 2024 Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on.
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Cognition Therapeutics Announces Pricing of $11 5 Million Public Offering of Common Stock streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cognition Therapeutics Announces Proposed Public Offering of Common Stock businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
PURCHASE, N. Y., March 11, 2024 Cognition Therapeutics, Inc. , a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has.